← Back to Search

Behavioral Intervention

Cognitive rehabilitation program for Acute Lymphoblastic Leukemia

N/A

Recruiting

Led By Susan Hiniker

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

All patients must have a histologic or cytological diagnosis of ALL treated with stem cell transplantation. There are no restrictions on prior therapy.

Patient and/or parents/guardians as appropriate must sign an informed consent, be mentally responsible, able to understand and willing to sign a written informed consent.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 26 weeks after transplant

Awards & highlights

Study Summary

This trial will test how well a new iPad-based treatment works for people with cognitive problems after a heart transplant.

Who is the study for?

This trial is for children and young adults aged 6 to 21 with Acute Lymphoblastic Leukemia (ALL) who have undergone stem cell transplantation. Participants must be able to understand and consent to the study, or have guardians who can. There are no limits on previous treatments, but pregnant individuals or those with serious medical issues that could interfere with the trial cannot join.Check my eligibility

What is being tested?

The study tests an iPad-based cognitive rehabilitation program designed for pediatric patients recovering from a stem cell transplant due to ALL. The focus is on how feasible it is for participants to follow this program and how their brain function scores change after treatment and over time.See study design

What are the potential side effects?

Since this intervention involves cognitive exercises using an iPad, there are no direct physical side effects like you'd expect from medication. However, fatigue or frustration may occur if tasks become challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have ALL and have been treated with a stem cell transplant.

Select...

I (or my guardian) understand and agree to participate in the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 26 weeks after transplant

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~26 weeks after transplant

This trial's timeline: 3 weeks for screening, Varies for treatment, and 26 weeks after transplant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants who complete the post-transplant neurocognitive intervention program

Trial Design

1Treatment groups

Experimental Treatment

Group I: Cognitive rehabilitation armExperimental Treatment1 Intervention

Cognitive rehabilitation program

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cognitive rehabilitation program

2015

N/A

~80

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,393 Previous Clinical Trials

17,341,251 Total Patients Enrolled

Susan HinikerPrincipal InvestigatorStanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I feasibly take part in this medical experiment?

"Patients aged between 6 and 21, who have undergone transplantation or stem cell treatment, are eligible for enrollment in this medical trial. In total, 35 people will be accepted into the study."

Answered by AI

Is this trial accepting new participants at this time?

"Records hosted on clinicaltrials.gov show that this research project is still searching for participants, with the original posting taking place in December 2014 and the most recent update happening in January 2022."

Answered by AI

How many participants are receiving treatment through this clinical trial?

"Affirmative, clinicaltrials.gov data demonstrate that this investigation is presently enrolling individuals. It was initially posted on December 1st 2014 and lastly adjusted on January 14th 2022. 35 patients are needed to be onboarded at a single medical site."

Answered by AI

Are individuals aged 45 years or older being included in this medical experiment?

"To be accepted into this medical experiment, participants must range between 6 and 21 years old. Notably, there are 331 trials for those below 18 and 310 for the elderly population."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility Neurocognitive Outcome After Transplant

2014. "Feasibility Neurocognitive Outcome After Transplant". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02300961.

All > Pediatric Cancer